Literature DB >> 11398608

Split-course radiotherapy: where do we stand?

H H Dubben1, A Krüll, H P Beck-Bornholdt.   

Abstract

BACKGROUND: Split-course radiotherapy is only rarely applied in curative radiotherapy and there might be a number of arguments to believe that continuous radiotherapy is superior to split-course treatment. In order to point out the evidence current treatment practice is based on, the available randomized trials and some prominent retrospective analyses on split-course radiotherapy were critically assessed.
MATERIAL AND METHODS: The analysis of the clinical results was based on published data only. Publications were searched in a Medline database.
RESULTS: Assessment of 13 randomized trials, including the data of 2,112 patients, revealed no significant difference between continuous-course and split-course radiotherapy. Astonishingly, the outcome of 77 radiotherapy studies on split-course, most of which are retrospective, seems to depend on the year of publication, suggesting publication bias.
CONCLUSIONS: No clinically relevant difference between continuous and split-course radiotherapy could be found. This, of course, does not proof that there are indeed no differences but the data do not allow to draw clear-cut conclusions in favor of or against split-course radiotherapy due to methodological shortcomings of the studies.

Entities:  

Mesh:

Year:  2001        PMID: 11398608     DOI: 10.1007/pl00002402

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  2 in total

1.  Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.

Authors:  Eun Kyung Paik; Mi-Sook Kim; Young-Seok Seo; Won Il Jang; Jin-Kyu Kang; Chul-Koo Cho; Hyung Jun Yoo
Journal:  Jpn J Clin Oncol       Date:  2018-06-01       Impact factor: 3.019

2.  Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution.

Authors:  Byoung Hyuck Kim; Eui Kyu Chie; Kyubo Kim; Jin-Young Jang; Sun Whe Kim; Do-Youn Oh; Yung-Jue Bang; Sung W Ha
Journal:  Oncotarget       Date:  2017-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.